Tag: cancer
Pyxis Oncology to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary...
The US Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications from Cambridge, Massachusetts-based biotech Pyxis Oncology, allowing the company to...
Corbus Expands Oncology Pipeline with Clinical Stage Nectin-4 Targeting ADC
Corbus Pharmaceuticals, a precision oncology company, today announced that it has entered into an exclusive licensing agreement with CSPC Megalith Biopharmaceutical, a subsidiary of...
Adcendo Licenses Duality Biologics’ DITAC Linker-Payload Technology Platform for its Lead...
Denmark's Adcendo, a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of underserved cancers, has signed a licensing agreement with Duality Biologics, a clinical-stage biotech company focused on discovering and developing a pipeline of ADCs targeting cancers and autoimmune diseases.
Eric Rosenthal Reports: Why Academia Wasn’t Ready to Build Big Data...
Big news hit the pharmaceutical industry in February when Roche Pharmaceuticals announced that it would be acquiring big-data firm Flatiron Health for $1.9 billion.
Roche...
Novel Approach may Limit the Troubling Side Effects of Cancer Immunotherapy
Connecting highly effective cancer immunotherapy drugs such as anti-CTLA4 (ipilimumab | Yervoy®; Bristol-Myers Squibb Company) and anti-PD-L1 (atezolizumab | Tecentriq®; Genentech) to peptides that...
Study looks at Efficacy and Metabolism of Azonafide-based ADCs in Microgravity
A new study is investigating the efficacy and metabolism of azonafide-based antibody-drug conjugates (ADCs) in microgravity. The investigators seeks to activate immunogenic cell death...
What Governments Can Do To Address Cancer
While much work remains to find a cure for cancer – the good news is we know that many forms of cancer are preventable....
To Reimburse or not to Reimburse – That is the Question
Novel, innovative (bio)pharmaceutical drugs are an important part of our global healthcare system, offering advanced, radical new personalized and targeted therapy options to patients...
Antibody-drug conjugates: Recent Advances in Conjugation and Linker Chemistries
Authors: Tsuchikama K , An Z
Title: Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
Published in: Protein Cell. 2016 Oct 14.
Keywords: antibody-drug conjugates; cancer;...
Outsmarting Cancer – From the War on Cancer to the Cancer...
On May 25, 1961, President John F. Kennedy announced, before a special joint session of congress, the dramatic and ambitious goal of sending a...
